Nicotine induces oral dysplastic keratinocyte migration via fatty acid synthase-dependent epidermal growth factor receptor activation

Exp Cell Res. 2018 Sep 15;370(2):343-352. doi: 10.1016/j.yexcr.2018.06.036. Epub 2018 Jun 30.

Abstract

Despite advances in diagnostic and therapeutic management, oral squamous cell carcinoma (OSCC) patient survival rates have remained relatively unchanged. Thus, identifying early triggers of malignant progression is critical to prevent OSCC development. Traditionally, OSCC initiation is elicited by the frequent and direct exposure to multiple tobacco-derived carcinogens, and not by the nicotine contained in tobacco products. However, other nicotine-containing products, especially the increasingly popular electronic cigarettes (e-cigs), have unknown effects on the progression of undiagnosed tobacco-induced oral premalignant lesions, specifically in regard to the effects of nicotine. Overexpression of fatty acid synthase (FASN), a key hepatic de novo lipogenic enzyme, is linked to poor OSCC patient survival. Nicotine upregulates hepatic FASN, but whether this response occurs in oral dysplastic keratinocytes is unknown. We hypothesized that in oral dysplastic keratinocytes, nicotine triggers a migratory phenotype through FASN-dependent epidermal growth factor receptor (EGFR) activation, a common pro-oncogenic event supporting oral carcinogenesis. We report that in oral dysplastic cells, nicotine markedly upregulates FASN leading to FASN-dependent EGFR activation and increased cell migration. These results raise potential concerns about e-cig safety, especially when used by former tobacco smokers with occult oral premalignant lesions where nicotine could trigger oncogenic signals commonly associated with malignant progression.

Keywords: Cell migration; EGFR; FASN; Nicotine; Oral cancer; Oral premalignant lesions.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinogenesis / drug effects
  • Carcinogenesis / pathology
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / pathology
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Electronic Nicotine Delivery Systems / methods
  • ErbB Receptors / drug effects*
  • ErbB Receptors / metabolism
  • Fatty Acid Synthases / drug effects
  • Fatty Acid Synthases / metabolism
  • Humans
  • Keratinocytes / drug effects*
  • Keratinocytes / metabolism
  • Mouth Neoplasms / drug therapy
  • Mouth Neoplasms / pathology
  • Nicotine / pharmacology*
  • Precancerous Conditions / drug therapy
  • Precancerous Conditions / pathology
  • Up-Regulation

Substances

  • Nicotine
  • Fatty Acid Synthases
  • ErbB Receptors